Cargando…
Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing Sarcoma
Monocyte-derived dendritic cell (DC)-based vaccines loaded with tumor self-antigens represent a novel approach in anticancer therapy. We evaluated DC-based anticancer immunotherapy (ITx) in an academic Phase I/II clinical trial for children, adolescent, and young adults with progressive, recurrent,...
Autores principales: | Fedorova, Lenka, Mudry, Peter, Pilatova, Katerina, Selingerova, Iveta, Merhautova, Jana, Rehak, Zdenek, Valik, Dalibor, Hlavackova, Eva, Cerna, Dasa, Faberova, Lucie, Mazanek, Pavel, Pavelka, Zdenek, Demlova, Regina, Sterba, Jaroslav, Zdrazilova-Dubska, Lenka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868036/ https://www.ncbi.nlm.nih.gov/pubmed/31799177 http://dx.doi.org/10.3389/fonc.2019.01169 |
Ejemplares similares
-
Dendritic Cell-Based Immunotherapy in Advanced Sarcoma and Neuroblastoma Pediatric Patients: Anti-cancer Treatment Preceding Monocyte Harvest Impairs the Immunostimulatory and Antigen-Presenting Behavior of DCs and Manufacturing Process Outcome
por: Hlavackova, Eva, et al.
Publicado: (2019) -
B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia
por: Rihacek, Michal, et al.
Publicado: (2015) -
Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidedness
por: Bencsikova, Beatrix, et al.
Publicado: (2019) -
Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize
por: Kýr, Michal, et al.
Publicado: (2020) -
Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology
por: Pilatova, Katerina, et al.
Publicado: (2013)